Norman Schwartz has literally grown up in the executive suite of Bio-Rad Laboratories. He says he doesn’t remember, but there is a family story about his crib being in the back of the company’s offices.

Today, Schwartz, 54, the son of Bio-Rad Laboratories founders David and Alice Schwartz, is the CEO and president of the 4,800-employee company, which was founded in 1957.

BioCommerce Week spoke to Schwartz this week at the JPMorgan Healthcare Conference in San Francisco about his vision for Bio-Rad’s strategy for growth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.